Long-term Cause-specific Mortality of Adolescent and Young Adult (AYA) Survivors of Bone and Soft Tissue Sarcoma (STS): A Population-based Study

2011 ◽  
Vol 81 (2) ◽  
pp. S137-S138
Author(s):  
P. Youn ◽  
N. Howlader ◽  
M.T. Milano ◽  
L.S. Constine ◽  
L.B. Travis
Keyword(s):  
Young Adult ◽  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Population Based ◽  
Adolescent And Young Adult ◽  
Population Based Study ◽  
Specific Mortality

scholarly journals Fertility preservation knowledge, counseling, and actions among adolescent and young adult patients with cancer: A population-based study

Cancer ◽  
2015 ◽  
Vol 121 (19) ◽  
pp. 3499-3506 ◽  
Author(s):  
Margarett Shnorhavorian ◽  
Linda C. Harlan ◽  
Ashley Wilder Smith ◽  
Theresa H.M. Keegan ◽  
Charles F. Lynch ◽  
...  
Keyword(s):  
Young Adult ◽  
Fertility Preservation ◽  
Population Based ◽  
Adult Patients ◽  
Adolescent And Young Adult ◽  
Population Based Study ◽  
Patients With Cancer

Rates of survival throughout the years in soft tissue sarcoma with synchronous metastases: Results of a population-based study.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 11068-11068
Author(s):  
Melissa Vos ◽  
Vincent K.Y. Ho ◽  
Astrid W. Oosten ◽  
Cornelis Verhoef ◽  
Stefan Sleijfer
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
The Netherlands ◽  
Population Based ◽  
Favorable Effect ◽  
Adult Type ◽  
Population Based Study ◽  
Primary Tumor Site ◽  
Synchronous Metastases

11068 Background: Roughly 10% of patients with soft tissue sarcoma (STS) present with synchronous metastases and generally cannot be cured anymore. With the registration of trabectedin, pazopanib and the identification of other agents exerting activity against STS, the treatment of these patients in the Netherlands has changed considerably in the last decade. The aim of this population-based study is to examine whether the overall survival (OS) of patients with STS and synchronous metastases has improved over the years. Methods: All patients diagnosed with adult-type STS and synchronous metastases between 1989 and 2014 were queried from the Netherlands Cancer Registry. Trends in OS were assessed by the Kaplan Meier method and log rank test in different timeframes based on year of registration of trabectedin ( < 2007 vs. ≥2007) and pazopanib ( < 2012 vs. ≥2012). A multivariable Cox regression analysis was performed to identify relevant characteristics prognostic for OS. Results: In total, 1,393 patients with adult-type STS and synchronous metastases were identified. Over the whole time period, median OS did not improve significantly (5.8 months in 1989-1994 to 8.1 months in 2010-2014, p = 0.095), but median OS < 2007 compared to ≥2007 did improve significantly (5.8 months to 7.3 months, p = 0.035). This was particularly apparent in the liposarcoma subgroup, where median OS doubled (5.2 months to 11.5 months, p = 0.020). Median OS < 2012 compared to ≥2012 did not increase significantly (6.1 months to 7.6 months, p = 0.062), though there was a relatively short follow-up of 2 years while the survival curve seems to reach a plateau phase. Aside from not receiving (any type of) treatment, elderly age, STS subtype other than lipo- or leiomyosarcoma, high or unknown grade and nodal involvement were significant negative predictors for OS, whereas primary tumor site in the extremity and surgery in an academic center had a favorable effect on OS. Conclusions: OS of STS patients with synchronous metastases has not improved significantly over the years, except for the subgroup of liposarcomas after 2007. A longer follow-up period is needed to clarify the impact of pazopanib on OS in patients with metastatic STS.

scholarly journals Childbirth after adolescent and young adult cancer: a population-based study

2018 ◽  
Vol 12 (4) ◽  
pp. 592-600 ◽  
Author(s):  
Hazel B. Nichols ◽  
Chelsea Anderson ◽  
Kathryn J. Ruddy ◽  
Kristin Z. Black ◽  
Barbara Luke ◽  
...  
Keyword(s):  
Young Adult ◽  
Population Based ◽  
Adolescent And Young Adult ◽  
Population Based Study ◽  
Young Adult Cancer
Sign in / Sign up

Export Citation Format

Share Document